US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

268.16

+2.370.89%

Volume:42.26K

Turnover:11.14M

Market Cap:609.93M

PE:- -

High:268.34

Open:261.76

Low:260.00

Close:265.79

52wk High:341.93

52wk Low:93.20

Shares:2.27M

Float Shares:2.27M

Volume Ratio:5.07

T/O Rate:1.86%

Dividend:0.90

Dividend Rate:0.34%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Bernstein Remains a Hold on Avantor (AVTR)

Analysts Conflicted on These Healthcare Names: Harmony Biosciences Holdings (HRMY), BioNTech SE (BNTX) and Biogen (BIIB)

Exchange-Traded Funds Rise US Equities Advance After Midday

MT Newswires Live

Worldwide Healthcare Trust Boosts Treasury Stock With Share Buyback

Newron Faces Ongoing FDA Hold on U.S. Arm of Key Evenamide Schizophrenia Trial

Pharming Says FDA Accepts sNDA for Lower-Dose Joenja in Children With APDS

MT Newswires Live

Quantum BioPharma (NASDAQ: QNTM) Receives FDA Green Light to Move Lucid-MS into Phase 2 Testing

Pharming Wins FDA Priority Review for Lower-Dose Joenja in Younger APDS Patients

Pharming announces FDA acceptance, Priority review of sNDA for Joenja

Analysts Offer Insights on Healthcare Companies: Owlet (OWLT) and Lifestance Health Group (LFST)

Pharming announces U.S. FDA acceptance and Priority Review of sNDA for lower doses of Joenja® to treat children with APDS

Sector Update: Healthcare Stocks Edge Higher Premarket Friday

MT Newswires Live

Analysts Offer Insights on Healthcare Companies: AMN Healthcare Services (AMN) and Cullinan Management (CGEM)

Analysts Offer Insights on Healthcare Companies: Damora Therapeutics (DMRA) and Nanobiotix (NBTX)

Health Care Select Sector SPDR: Pivot points

Rezolute: Buy Rating Reiterated as FDA Engagement and Strong HI Data Support Unchanged $6 Price Target

Analysts Offer Insights on Healthcare Companies: RegenXBio (RGNX) and Resmed (RMD)

Grail price target raised to $100 from $65 at Mizuho

Sunway Healthcare's Unit to Acquire Freehold Land in Related Party Deal

MT Newswires Live

Merck, Eisai Get FDA OK of Welireg/Lenvima Combo in Kidney Cancer

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/LABU/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":268.1602,"timestamp":1790861956072,"preClose":265.79,"halted":0,"volume":42260,"delay":0,"changeRate":0.008917566499868145,"floatShares":2274486,"shares":2274486,"eps":0,"marketStatus":"Trading","change":2.3702,"latestTime":"10-01 09:39:33 EDT","open":261.76,"high":268.34,"low":260,"amount":11140778.1316,"amplitude":0.031378,"askPrice":268.51,"askSize":1,"bidPrice":266.89,"bidSize":10,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1790884800000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":265.79,"sharesOutstanding":3074486,"nav":260.661,"aum":592869955.42,"dividendRate":0.00337,"bidAskSpread":0.003436,"preHourTrading":{"tag":"盘前","latestPrice":261.6,"preClose":265.79,"latestTime":"09:29 EDT","volume":2318,"amount":612617.1732800001,"timestamp":1790861345993,"change":-4.19,"changeRate":-0.015764,"amplitude":0.02976},"postHourTrading":{"tag":"盘后","latestPrice":266.5,"preClose":265.79,"latestTime":"19:59 EDT","volume":2105,"amount":559351.6497,"timestamp":1790812786487,"change":0.71,"changeRate":0.002671,"amplitude":0.007525},"volumeRatio":5.073207,"impliedVol":0.9572,"impliedVolPercentile":0.6813},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":2274486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":5.073207,"shares":2274486,"dividePrice":0.9037,"high":268.34,"amplitude":0.031378,"preClose":265.79,"low":260,"week52Low":93.2,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":268.1602,"committee":0.818182,"eps":0,"divideRate":0.00337,"volume":42260,"delay":0,"ttmEps":0,"open":261.76,"prevYearClose":159.39,"prevWeekClose":252.47,"prevMonthClose":265.79,"prevQuarterClose":265.79,"fiveDayClose":257.32,"twentyDayClose":311.81,"sixtyDayClose":317.19},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2670429439","title":"Bernstein Remains a Hold on Avantor (AVTR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2670429439","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670429439?lang=en_us&edition=fundamental","pubTime":"2026-09-26 01:35","pubTimestamp":1790357725,"startTime":"0","endTime":"0","summary":"Bernstein analyst Eve Burstein maintained a Hold rating on Avantor today and set a price target of $15.50. Burstein covers the Healthcare sector, f...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/bernstein-remains-a-hold-on-avantor-avtr-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/bernstein-remains-a-hold-on-avantor-avtr-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","BK4588","LABU","XLV","LU0006061336.USD","BK4585","BK4581","BK4121","AVTR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670342945","title":"Analysts Conflicted on These Healthcare Names: Harmony Biosciences Holdings (HRMY), BioNTech SE (BNTX) and Biogen (BIIB)","url":"https://stock-news.laohu8.com/highlight/detail?id=2670342945","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670342945?lang=en_us&edition=fundamental","pubTime":"2026-09-26 01:30","pubTimestamp":1790357441,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Harmony Biosciences Holdings (HRMY), BioNTech SE (BNTX) and Bioge...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-harmony-biosciences-holdings-hrmy-biontech-se-bntx-and-biogen-biib-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-harmony-biosciences-holdings-hrmy-biontech-se-bntx-and-biogen-biib-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2065171402.SGD","BIIB","HRMY","SE","PBE","LU0210637038.USD","XBI","LU0251143029.SGD","LU0532188223.SGD","LU0737861269.HKD","LU2125910849.SGD","HCSG","LU0128526141.USD","IE0031814969.USD","LU1861220207.SGD","LU0499858602.USD","LU0261945553.USD","BK4548","LU0441851309.USD","BK4566","LU0109394709.USD","LU0589944569.HKD","LU2360107671.USD","LU1839390173.USD","LABU","FDNI","XLV","IE00B19Z9P08.USD","IE00BD6J9T35.USD","LU0889565916.HKD","LU1770036033.HKD","IE0034224299.USD","SG9999002406.SGD","BMED","SG9999002620.SGD","BK4532","BNTX","LU2065169927.USD","LU2152927971.USD","LU0264606111.USD","LU0234570918.USD","LU0979878070.USD","LU1242518857.USD","LU0516422366.SGD","LU0516423091.SGD","SG9999013478.USD","SGXZ58947870.SGD","LU2008162690.USD","LU0029874061.USD","LU0516422440.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670429533","title":"Exchange-Traded Funds Rise US Equities Advance After Midday","url":"https://stock-news.laohu8.com/highlight/detail?id=2670429533","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670429533?lang=en_us&edition=fundamental","pubTime":"2026-09-26 01:20","pubTimestamp":1790356854,"startTime":"0","endTime":"0","summary":"Broad Market IndicatorsBroad-market exchange-traded funds IWM and IVV edged higher. Actively traded Invesco QQQ Trust (QQQ) added 0.5% after midday Friday.US equity indexes rose as crude oil prices fe","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["QQQM","BAGY","ETCO","BK4547","EZBC","BTC.USD.CC","SOXL","BRRR","BTCC","CBXY","ETH.USD.CC","BTF","VHT","BGLD","XLY","CBTO","IYH","BTCO","XLP","FAZ","CBOY","DZZ","BTRN","RETL","DFII","GPIQ","IGLD","UCO","VIS","BAR","TETH","SOXS","XLV","NAPR","XAGUSD.FOREX","GLL","GBTC","XLE","IBIT","XLPU","IAUM","ETQ","CBTJ","QBF","BITO","XSD","DEFI","GLDM","DGP","TECL","AGQ","CBOO","LABU","BTCI","QLD","BK4550","BITY","BITX","AAAU","BK4581","BTCZ","QQQ","BK4534","BK4585","XBTY","XBI","CBTA","XAUUSD.FOREX","NJAN","IAU","YBTC","UGL","SETH","FAS","XLK","IYE","MNRS","GLD","DULL","FGDL","ARKB","SOXX","ZSL","NJUL","FBTC","UNG","BITI","BTCL","PSQ","CBTY","ETH","ETHD","SLV","BETH","KGLD","BITU","QQQX","BFAP","IBB","SIVR","SGOL","XLF","XLI","BK4588","GLDY","CBXA","SQQQ","HODL","YGLD","IGM","OUNZ","BETE","CBXJ","ETHT","CBOA","EETH","IAUI","BFJL","QDEC","BK4561","BCCC","BK4570","SHNY","NDX","BK4593","ESK","MAXI","BTCW","IYW","BTC","SBIT","DGZ","TQQQ","BITB","BPI","USO","XLPD","TQQY","USG","XRT","SCO","BK4504","CBXO","IYJ","NOCT","QID","RTH","CBOJ","QMAR","VDC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670442603","title":"Worldwide Healthcare Trust Boosts Treasury Stock With Share Buyback","url":"https://stock-news.laohu8.com/highlight/detail?id=2670442603","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670442603?lang=en_us&edition=fundamental","pubTime":"2026-09-26 00:42","pubTimestamp":1790354562,"startTime":"0","endTime":"0","summary":"Worldwide Healthcare Trust PLC GBP ( ($GB:WWH) ) has provided an announcement. Worldwide Healthcare Trust PLC has executed a market purchase of 1,5...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/worldwide-healthcare-trust-boosts-treasury-stock-with-share-buyback-5?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/worldwide-healthcare-trust-boosts-treasury-stock-with-share-buyback-5?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LU0029874061.USD","XBI","BK4588","XLV","BK4137","HCSG","LU0128526141.USD","LABU","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670426622","title":"Newron Faces Ongoing FDA Hold on U.S. Arm of Key Evenamide Schizophrenia Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2670426622","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670426622?lang=en_us&edition=fundamental","pubTime":"2026-09-26 00:03","pubTimestamp":1790352203,"startTime":"0","endTime":"0","summary":"Newron Pharmaceuticals SpA ( ($CH:NWRN) ) has shared an announcement. Newron Pharmaceuticals reported that recruitment of new patients at U.S. site...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/newron-faces-ongoing-fda-hold-on-u-s-arm-of-key-evenamide-schizophrenia-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/newron-faces-ongoing-fda-hold-on-u-s-arm-of-key-evenamide-schizophrenia-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670251404","title":"Pharming Says FDA Accepts sNDA for Lower-Dose Joenja in Children With APDS","url":"https://stock-news.laohu8.com/highlight/detail?id=2670251404","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670251404?lang=en_us&edition=fundamental","pubTime":"2026-09-25 23:38","pubTimestamp":1790350705,"startTime":"0","endTime":"0","summary":"Pharming  said Friday the US Food and Drug Administration accepted its supplemental new drug application seeking approval of lower doses of Joenja for children aged four and older who weigh between 13 kg and 27 kg and have activated phosphoinositide 3-kinase delta syndrome, a rare genetic immunodeficiency disease.The application received priority review, with an FDA target action date of Jan. 30, 2027.Pharming said the filing is supported by positive phase 3 data showing reduced lymphadenopathy and increased naive B cells after 12 weeks in children ages four to 11.Price: 10.62, Change: +0.18, Percent Change: +1.72","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PHAR","BK4585","BK4588","BK4139","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670463425","title":"Quantum BioPharma (NASDAQ: QNTM) Receives FDA Green Light to Move Lucid-MS into Phase 2 Testing","url":"https://stock-news.laohu8.com/highlight/detail?id=2670463425","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670463425?lang=en_us&edition=fundamental","pubTime":"2026-09-25 23:30","pubTimestamp":1790350237,"startTime":"0","endTime":"0","summary":"Austin, Texas, United States, September 25th, 2026, FinanceWire The FDA IND approval marks a pivotal step for the company’s lead compound, kn...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/newswire/quantum-biopharma-nasdaq-qntm-receives-fda-green-light-to-move-lucid-ms-into-phase-2-testing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/newswire/quantum-biopharma-nasdaq-qntm-receives-fda-green-light-to-move-lucid-ms-into-phase-2-testing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NQmain","NVIW.SI","BK4555","ONEQ","QQQY","TQQY","LCIZ","NDX",".IXIC","QQQJ","TECS","BK4551","QQQA","03086","GPIQ","LCDL","TQQQ","QID","BK4585","LABU","FTEC","IND","PSQ","SQQQ","BK4596","QNTM","BK4099","QQQE","QQQM","QDTE","MNQmain","JEPQ","QYLG","QLD","QQQ","BK4588","IYW","BK4007","LCID"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670425526","title":"Pharming Wins FDA Priority Review for Lower-Dose Joenja in Younger APDS Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2670425526","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670425526?lang=en_us&edition=fundamental","pubTime":"2026-09-25 23:03","pubTimestamp":1790348607,"startTime":"0","endTime":"0","summary":"Pharming Group ( ($NL:PHARM) ) has issued an update. Pharming Group has secured U.S. FDA acceptance and Priority Review for a supplemental New Drug...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pharming-wins-fda-priority-review-for-lower-dose-joenja-in-younger-apds-patients?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pharming-wins-fda-priority-review-for-lower-dose-joenja-in-younger-apds-patients?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670237284","title":"Pharming announces FDA acceptance, Priority review of sNDA for Joenja","url":"https://stock-news.laohu8.com/highlight/detail?id=2670237284","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670237284?lang=en_us&edition=fundamental","pubTime":"2026-09-25 22:35","pubTimestamp":1790346922,"startTime":"0","endTime":"0","summary":"Pharming (PHAR) announced that the U.S. Food and Drug Administration has accepted its supplemental New Drug Application seeking approval for lower ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/pharming-announces-fda-acceptance-priority-review-of-snda-for-joenja-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/pharming-announces-fda-acceptance-priority-review-of-snda-for-joenja-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4588","BK4139","PHAR","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670642304","title":"Analysts Offer Insights on Healthcare Companies: Owlet (OWLT) and Lifestance Health Group (LFST)","url":"https://stock-news.laohu8.com/highlight/detail?id=2670642304","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670642304?lang=en_us&edition=fundamental","pubTime":"2026-09-25 22:30","pubTimestamp":1790346658,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Owlet (OWLT) and Lifestance Health Group (LFST) with...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-owlet-owlt-and-lifestance-health-group-lfst-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-owlet-owlt-and-lifestance-health-group-lfst-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","BK4585","BK4588","BK4137","LABU","LU0128526141.USD","BK4082","XLV","OWLT","LU0029874061.USD","BK4535","BK4196","LFST","XBI","FMED","HCSG","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670423946","title":"Pharming announces U.S. FDA acceptance and Priority Review of sNDA for lower doses of Joenja® to treat children with APDS","url":"https://stock-news.laohu8.com/highlight/detail?id=2670423946","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670423946?lang=en_us&edition=fundamental","pubTime":"2026-09-25 22:30","pubTimestamp":1790346600,"startTime":"0","endTime":"0","summary":"If approved, Joenja would be available to eligible patients aged 4 years and older with APDS who weigh 13 kg or moreDecision follows recent approval of Joenja for children aged 4 to 11 years with APDS","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/25/3369191/0/en/pharming-announces-u-s-fda-acceptance-and-priority-review-of-snda-for-lower-doses-of-joenja-to-treat-children-with-apds.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670440027","title":"Sector Update: Healthcare Stocks Edge Higher Premarket Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=2670440027","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670440027?lang=en_us&edition=fundamental","pubTime":"2026-09-25 21:19","pubTimestamp":1790342373,"startTime":"0","endTime":"0","summary":"Healthcare stocks were edging higher premarket Friday, with the State Street Health Care Select Sector SPDR ETF (XLV) up 0.1% and the iShares Biotechnology ETF (IBB) advancing by 0.5%.STAAR Surgical (","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2237443549.SGD","GDOC","JDOC","LU0234572021.USD","LU0354030511.USD","LU2089284900.SGD","LU2168564065.EUR","LU0323591593.USD","LU2213496289.HKD","LU2750360997.AUD","BK4007","LU0114720955.EUR","SGXZ51526630.SGD","SG9999014898.SGD","LU0203201768.USD","LU2491050071.SGD","IE00B1BXHZ80.USD","IE00BJJMRX11.SGD","LU0456855351.SGD","LU0683600562.USD","BK4139","LU2023250330.USD","SG9999014906.USD","IE0009355771.USD","LU2271345857.HKD","LU1280957306.USD","LU2237443465.HKD","LU2471134879.HKD","MEDI","IE00B7KXQ091.USD","BK4581","GB00BDT5M118.USD","LU0320765059.SGD","LU0432979614.USD","LU1035775433.USD","LU2746668461.USD","LU2168564495.EUR","IE00BK4W5M84.HKD","LU2236285917.USD","LU2471134952.CNY","LU2108987350.USD","LU0096364046.USD","LU0689472784.USD","LU0820561909.HKD","LU2087625088.SGD","IE0004445015.USD","LU0094547139.USD","LU2211815571.USD","LU2456880835.USD","BK4516","LU1691799644.USD","LU2112291526.USD","LU1366192091.USD","SG9999018865.SGD","LU2491049909.HKD","LU0385154629.USD","LU0345770308.USD","LU1548497426.USD","SG9999013999.USD","LU0316494557.USD","LU1069344957.HKD","LU1629891620.HKD","IE00B1XK9C88.USD","CURE","LU0466842654.USD","LU2361045086.USD","LU1983299246.USD","IE0001KFT4U8.USD","ELIS","LU0266013472.USD","LU1267930730.SGD","LU0109391861.USD","LU1551013425.SGD","LU1974910355.USD","LU2265009873.SGD","NKTR","IE00BFTCPJ56.SGD","LU2491050154.USD","LU0158827781.USD","TMED","LU0106261372.USD","LU0225283273.USD","LU2461242641.AUD","LU1868836757.USD","LU0417517546.SGD","LU0353189680.USD","LU1804176565.USD","LU1712237335.SGD","LU2023251221.USD","PJP","LU0133085943.USD","IYH","LU2462157665.USD","VHT","LU0210536198.USD","BK4534","LU2471134523.USD","LU0320765992.SGD","LU0061475181.USD","IE00BWXC8680.SGD","LU0238689110.USD","LU2111349929.HKD","LU1064131342.USD","LU0122379950.USD","IE00BJJMRY28.SGD","PPH","LU2896262040.SGD","LU0345770993.USD","LLYZ","ELIL","LU2756315664.SGD","LU2417539215.USD","LU0889565916.HKD","BK4533","LU0882574139.USD","IE00BFSS8Q28.SGD","LU2237443978.SGD","LU2552382215.SGD","IE00BN29S564.USD","LU0289739699.SGD","THNR","LU0672654240.SGD","CANC","XLV","LU0823434740.USD","LLY","LU1127390331.HKD","LU2168563687.JPY","IHE","LU0820562030.AUD","LU0203202063.USD","LU1023059063.AUD","FATE","IE0004445239.USD","IE00BKDWB100.SGD","LU0820561818.USD","LU0471298777.SGD","MEDX","FHLC","LU0097036916.USD","LU0006306889.USD","LU0079474960.USD","LU0158827948.USD","LU1979441026.SGD","SGXZ31699556.SGD","LU2237443895.HKD","LU2462591350.SGD","LU2360106947.USD","LU0256863811.USD","LU1061106388.HKD","LLII","LU0943347566.SGD","LU2168564222.USD","LU2357305700.SGD","WDNA","LU0882574055.USD","IE00BJT1NW94.SGD","LU1232071149.USD","SG9999015952.SGD","SG9999014880.SGD","AGNG","BK4599","LU0353189763.USD","LU2468319806.SGD","LU1814569148.SGD","HRTS","RXL","LU2028103732.USD","LU1057294990.SGD","LU1551013342.USD","IE00B4JS1V06.HKD","LU2063271972.USD","LU2089283258.USD","SG9999014914.USD","LU2023250504.SGD","LU0354030438.USD","LU2237443622.USD","IE00B4R5TH58.HKD","LU0640476718.USD","LU1868837136.USD","LU2471134796.USD","BK4585","LU0256863902.USD","LU1623119135.USD","LU1868837300.USD","LU2750360641.GBP","LU0198837287.USD","BK4588","LU2552382132.HKD","IE0002141913.USD","IE0005OL40V9.USD","LU1989771016.USD","SGXZ57979304.SGD","SG9999015945.SGD","LU1868836914.USD","SGXZ99366536.SGD","LU1093756168.USD","LU1868836591.USD","OZEM","XBI","STAA","LU2756315318.SGD","IE00B2B36J28.USD","LU2237438978.USD","LU0058720904.USD","ILDR","IXJ","LU1291159041.SGD","LU2361044865.SGD","LU1720051108.HKD","LU2168564149.EUR","TRUH","LU0823416689.USD","LU2106854487.HKD","IE00BKPKM429.USD","LU2324357040.USD","LU2602419157.SGD","SG9999015986.USD","LU0471298694.HKD","LU2746668974.SGD","SG9999017495.SGD","SG9999015978.USD","LU2552382058.USD","LU0787776722.HKD","LU1720051017.SGD","LU1323610961.USD","LU0708995401.HKD","IE00BJLML261.HKD","LU0109394709.USD","LU0174119429.USD","LU1093756325.SGD","LU1988902786.USD","IE00BJJMRZ35.SGD","MHIP","SG9999001176.SGD","LU0786609619.USD","LU1917777945.USD","FTXH","SG9999001176.USD","LU0964807845.USD","BK4548","LABU","LU0823434583.USD","LLYX","LU2089984988.USD","LU2237443382.USD","IBB","LU2361044949.HKD","SG9999018857.SGD","IE00B775H168.HKD","SGXZ81514606.USD","IE00BK4W5L77.USD","LU1145028129.USD","IE00BFSS7M15.SGD","LU2264538146.SGD","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670440157","title":"Analysts Offer Insights on Healthcare Companies: AMN Healthcare Services (AMN) and Cullinan Management (CGEM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2670440157","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670440157?lang=en_us&edition=fundamental","pubTime":"2026-09-25 20:50","pubTimestamp":1790340613,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on AMN Healthcare Services (AMN) and Cullinan Managemen...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amn-healthcare-services-amn-and-cullinan-management-cgem-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amn-healthcare-services-amn-and-cullinan-management-cgem-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4196","BK4585","BK4139","LABU","AMN","XBI","BK4588","CGEM","BK4581","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670440538","title":"Analysts Offer Insights on Healthcare Companies: Damora Therapeutics (DMRA) and Nanobiotix (NBTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2670440538","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670440538?lang=en_us&edition=fundamental","pubTime":"2026-09-25 20:30","pubTimestamp":1790339445,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Damora Therapeutics (DMRA) and Nanobiotix (NBTX) wit...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-damora-therapeutics-dmra-and-nanobiotix-nbtx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-damora-therapeutics-dmra-and-nanobiotix-nbtx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","LU0128526141.USD","BK4588","BK4139","DMRA","XLV","LABU","LU0029874061.USD","NBTX","BK4581","HCSG","BK4585","LENZ","BK4007","BK4137","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670440589","title":"Health Care Select Sector SPDR: Pivot points","url":"https://stock-news.laohu8.com/highlight/detail?id=2670440589","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670440589?lang=en_us&edition=fundamental","pubTime":"2026-09-25 20:26","pubTimestamp":1790339175,"startTime":"0","endTime":"0","summary":"The following are the pivot points for the Health Care Select Sector SPDR (XLV). Pivot High: $172.11, Pivot Low: $169.30. These were calculated usi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/health-care-select-sector-spdr-pivot-points-thefly-news-150?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/health-care-select-sector-spdr-pivot-points-thefly-news-150?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4581","XLV","BK4585","LABU","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670744763","title":"Rezolute: Buy Rating Reiterated as FDA Engagement and Strong HI Data Support Unchanged $6 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2670744763","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670744763?lang=en_us&edition=fundamental","pubTime":"2026-09-25 19:55","pubTimestamp":1790337320,"startTime":"0","endTime":"0","summary":"Rezolute, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Yun Zhong from Wedbush maintained a Buy rating on th...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/rezolute-buy-rating-reiterated-as-fda-engagement-and-strong-hi-data-support-unchanged-6-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/rezolute-buy-rating-reiterated-as-fda-engagement-and-strong-hi-data-support-unchanged-6-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670476954","title":"Analysts Offer Insights on Healthcare Companies: RegenXBio (RGNX) and Resmed (RMD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2670476954","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670476954?lang=en_us&edition=fundamental","pubTime":"2026-09-25 19:40","pubTimestamp":1790336408,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on RegenXBio (RGNX) and Resmed (RMD). RegenXBio (RGNX...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-regenxbio-rgnx-and-resmed-rmd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-regenxbio-rgnx-and-resmed-rmd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4548","LU2177674079.SGD","LGHT","BK4137","BK4585","RGNX","XBI","BK4139","BK4505","LU0029874061.USD","BK4563","HCSG","BK4588","BK4581","LU0170899867.USD","LU0128526141.USD","BK4567","IE00B5TLWC47.USD","BK4082","LABU","BK4504","XLV","RMD","LU2008162690.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670442202","title":"Grail price target raised to $100 from $65 at Mizuho","url":"https://stock-news.laohu8.com/highlight/detail?id=2670442202","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670442202?lang=en_us&edition=fundamental","pubTime":"2026-09-25 19:36","pubTimestamp":1790336163,"startTime":"0","endTime":"0","summary":"Mizuho raised the firm’s price target on Grail (GRAL) to $100 from $65 and keeps a Neutral rating on the shares. The FDA panel voted that Galleri i...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/grail-price-target-raised-to-100-from-65-at-mizuho-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/grail-price-target-raised-to-100-from-65-at-mizuho-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4139","GRAL","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670423734","title":"Sunway Healthcare's Unit to Acquire Freehold Land in Related Party Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2670423734","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670423734?lang=en_us&edition=fundamental","pubTime":"2026-09-25 19:04","pubTimestamp":1790334242,"startTime":"0","endTime":"0","summary":"Sunway Healthcare's  subsidiary Sunway Medical Centre has entered into a sale and purchase agreement with Sunway Sentral Seremban for the acquisition of freehold land in Bandar Seremban, Negeri Sembilan, for 10.8 million ringgit.The acquisition is a related party transaction, as Sunway Sentral Seremban is a 70%-owned subsidiary of Sunway City Sdn Bhd, which in turn is a wholly-owned subsidiary of Sunway , while Sunway City also holds a 69.4% equity interest in SHH.The SPA is conditional upon the issuance of an individual title to the land in the name of Sunway Sentral Seremban, with the condition precedent to be fulfilled within 18 months plus an automatic three-month extension.SMC undertakes to develop and operate a medical centre as the primary use of the land, with completion expected in the first quarter of 2028, subject to contractual and development risks.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XBI","LU0029874061.USD","BK4588","LABU","XLV","BK4585","BK4581","HCSG","BK4137","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670442580","title":"Merck, Eisai Get FDA OK of Welireg/Lenvima Combo in Kidney Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2670442580","media":"Dow Jones","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670442580?lang=en_us&edition=fundamental","pubTime":"2026-09-25 19:04","pubTimestamp":1790334240,"startTime":"0","endTime":"0","summary":"Merck and Eisai have won U.S. Food and Drug Administration approval of the dual oral regimen of Merck's Welireg plus both companies' Lenvima in certain patients with the most common type of kidney cancer.The companies on Friday said the green light covers the combination in adults with advanced renal cell carcinoma with a clear cell component following a programmed death receptor-1 or programmed death-ligand 1 inhibitor.Welireg plus Lenvima is the first approved combination of a hypoxia-inducible factor-2 alpha inhibitor and a multi-targeted vascular endothelial growth factor receptor tyrosine kinase inhibitors for these patients, the companies said.Rahway, N.J., drugmaker Merck and Tokyo-based Eisai formed a collaboration in 2018 to jointly develop, manufacture and commercialize Lenvima, which Eisai discovered.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"Merck, Eisai Get FDA OK of Welireg/Lenvima Combo in Kidney Cancer","news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":20,"pageCount":9,"totalSize":384,"code":"91000000","status":"200"}]}}